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Background: Left bundle branch block (LBBB) morphology is associated with improved outcome of cardiac
resynchronisation therapy (CRT) and is an important criterion for patient selection. There are, however, multiple
definitions for LBBB. Moreover, applying these definitions seems subjective. We investigated the inter- and
intraobserver agreement in the determination of LBBBusing available definitions, and clinicians' judgement of LBBB.
Methods: Observers were provided with 12‑lead ECGs of 100 randomly selected CRT patients. Four observers
judged the ECGs based on different LBBB-definitions (ESC, AHA/ACC/HRS, MADIT, and Strauss). Additionally,
four implanting cardiologists scored the same 100 ECGs based on their clinical judgement. Observer agreement
was summarized through the proportion of agreement (P) and kappa coefficient (k).
Results: Relative intra-observer agreement using different LBBB definitions, and within clinical judgement was
moderate (range k 0.47–0.74 and k = 0.76 (0.14), respectively). The inter-observer agreement between ob-
servers using LBBB definitions as well as between clinical observers was minimal to weak (range k 0.19–0.44
and k = 0.35 (0.20), respectively). The probability of classifying an ECG as LBBB by available definitions varied
considerably (range 0.20–0.76). The agreement between different definitions of LBBB ranged from good
(P = 0.95 (0.07)) to weak (P = 0.40 (0.22)). Furthermore, correlation between the different LBBB definitions
and clinical judgement was poor (range phi 0.30–0.55).
Conclusion: Significant variation in the probability of classifying LBBB is present in using different definitions
and clinical judgement. Considerable intra- and inter-observer variability adds to this variation. Interdefinition
agreement varies significantly and correlation of clinical judgement with LBBB classification by definitions is
modest at best.
© 2019 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Cardiac resynchronisation therapy (CRT) is an established treatment
for heart failure patients with concomitant ventricular conduction
disturbances on the 12 lead ECG [1,2]. Studies have shown that the
presence of left bundle branch block (LBBB) is one of the best predic-
tors of response to CRT [3–6]. Therefore, current guidelines use LBBB
QRS morphology next to QRS duration as a tool for patient selection
for CRT [2]. Currently, patients with LBBB QRS morphology have a
class I recommendation for CRT, whereas patients with non-LBBB QRS
morphology have a class IIa or IIb recommendation depending on QRS
duration.
The use of the LBBB morphology in clinical practice is, however,
not straightforward. LBBB morphology has been defined differently by
the European and American cardiology societies [1,7], landmark trials
(REVERSE and MADIT-CRT) [4,6] and by experts [8]. In addition, ap-
plying these different definitions requires careful evaluation of the
ECG. Therefore, implanting cardiologists' judgement of the presence of
LBBB may not be in concordance with these definitions. Even when
the LBBB definitions would be used in clinical practice, they are exten-
sive (many criteria) and sensitive to different interpretations, which
may result in significant variation in patient selection for CRT.
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In this study we aim to investigate (1) the agreement in identifica-
tion of LBBB by clinical judgement of implanting cardiologists; (2) the
agreement in identification of LBBB using available LBBB definitions;
(3) the agreement between available LBBB definitions and (4) the
correlation between LBBB identification with use of definitions and of
clinical judgement by implanting cardiologists.
2. Methods
From a large cohort of over 500 consecutive patients implanted with a CRT device in
theUniversityMedical CentreUtrecht, 100 baseline 12‑lead ECGswere randomly selected.
The ECGs were recorded at 25 mm/s paper speed and displayed in a 2 × 6 lead fashion.
Four expert cardiologists involved in patient selection for CRT in daily clinical practice
(JL, AA, AM, KV) classified the presence of LBBB on the ECG according to their clinical
judgement. The ECGs were provided as printed 12-lead ECGs. For the classification of
LBBB according to the different LBBB definitions, four independent, trained observers
judged the ECGs according to four currently used LBBB definitions (Table 1). As can be
seen in Table 1, REVERSE-trial and ESCdefinition contain the samemorphological features.
Therefore the REVERSE-trial LBBB definitionwas not included as a separate definition. The
evaluation of the four different LBBB definitions was performed on digital ECGs (using up
to 400% zoom to judge the individual LBBB criteria). QRS duration was determined by the
automated ECG algorithm.
2.1. Statistical analysis
Intra-observer agreement for all five ways to determine LBBB was investigated using
repeated independent observations from two observers; both for definitions and clinical
judgement. Inter-observer agreement was defined between pairs of observers. Intra-
observer and inter-observer agreement levels were quantified in two ways: through the
probability to agree and through the kappa coefficient. While the first measure accounts
for disagreement on the classification of the ECGs themselves (absolute agreement), the
kappa coefficient also accounts for disagreement on the probability to be classified as
LBBBwith thedifferent definitions (including interobserver variability). Kappa coefficients
therefore mix two sources of disagreements (relative agreement). The effect of predictors
(type of criterion and QRS duration larger than 150 ms for clinical classification) on the
intra- and interobserver agreement levels and the probability of LBBB were analyzed
using a multilevel approach [9]. Random effects relative to the patients were introduced
in the models to capture the dependency between the multiple measurements made on
each patient (different pairs of observers using the same definition or the same observers
using different definitions). Large values of the variance of the random effects indicate
heterogeneous agreement levels, while small values indicate homogeneous agreement
levels. A Bayesian approach with vague priors was used to estimate the parameters in
the model. A predictor is said to be significant if the 95% equal-tailed posterior credibility
interval relative to the predictor does not contain the value 0. Posterior marginal distri-
butions were obtained by averaging over the random effects and are summarized
using posterior mean (posterior standard deviation). Data analysis was conducted
using R (version 3.2.5 for Windows) and JAGS statistical packages.
3. Results
Mean QRS duration of the patients was 160 ± 24 ms. Baseline char-
acteristics reflect a typical CRT population. Three patients had a QRS
duration shorter than 120 ms, and were implanted with a CRT device
for an ablate-and-pace indication.
3.1. Intra-observer agreement in LBBB classification
Overall absolute intraobserver agreement between LBBB definitions
is strong (P range 0.87–0.95), however relative agreement (kappa),
corrected for probability of the presence of LBBB, is only moderate
(k range 0.47–0.74). Intraobserver (absolute and relative) agreement
was lower with AHA/ACC/HRS definition than with ESC, MADIT and
Strauss definitions (Table 2). Within the AHA/ACC/HRS definition, the
agreement level on the detection of notched and slurred R criterion
was lower (P= 0.81 (0.09)) than on other criteria. Agreement on mor-
phological criteria of other LBBB definitions did not significantly differ.
Absolute Intra-observer agreement on clinical judgement was good
(P = 0.93 (0.05)), but only moderate relative agreement was found
(k = 0.76 (0.14)) (Table 2).
Absolute and relative agreement did not differ for patients with QRS
duration below and above 150ms (P=0.96 (0.09) and P=0.88 (0.16),
respectively).
3.2. Inter-observer agreement in LBBB classification
Absolute inter-observer agreementwas good for all LBBB definitions
(P range 0.81–0.88), however relative agreement (kappa) was minimal
to weak (range k 0.19–0.44) (Table 2). Agreement level in AHA/ACC/
HRS definition was reduced by variability in scoring notching/slurring
of the R-wave in leads I, aVL, V5 and V6, the absence of a Q-wave
in leads I, V5, V6 and aVL and R-peak time criteria (P = 0.73 (0.06),
P = 0.75 (0.07) and P = 0.71 (0.07), respectively).
The same trend was visible for clinical judgement of LBBB. Whereas
there was good absolute agreement of clinical judgement (P = 0.81
(0.81)), relative agreement is weak (k = 0.35 (0.20)) (Table 2).
QRS duration did not influence inter-observer variability (P = 0.73
(0.34) and P = 0.82 (0.19), for QRS duration below and above 150 ms
respectively) for clinical judgement.
3.3. General variation in observation of LBBB
There was a considerable difference in the probability of classifica-
tion as LBBB between the four available definitions and clinical judge-
ment, ranging between 0.20 (0.27) for AHA/ACC/HRS definition and
0.76 (0.29) for ESC definition (Fig. 1). The error bars in Fig. 1 indicate
large variability in scoring LBBB between the four observers, even
when using the same definition. The probability of being classified as
LBBB with clinical judgement was higher in patients with QRS duration
Table 1
Left bundle branch block definitions.
Definitions Criteria
ESC [1]/REVERSE [4] • QRS ≥120 ms
• QS or rS in V1
• Broad (frequently notched/slurred) R in I, aVL, V5 or V6
• Absent Q in V5 and V6
AHA/ACC/HRS [7] • QRS ≥120 ms
• Notch-, slurred R in I, aVL, V5 and V6
• Occasional RS pattern in V5–6
• Absent q in I, V5–V6 and aVL
• R peak time N60 ms in V5 and V6
• Normal R peak time in V1–V3
• No negative concordance
• Usually discordant ST-T segments
MADIT [6] • QRS ≥130 ms
• QS or rS in V1
• Broad (frequently notch-/slurred) R in I, aVL, V5 or V6
• Absent q in V5 and V6
Strauss [8] • QRS ≥130 ms in women, ≥140 ms in men
• QS or rS in V1 and V2
• Mid QRS notching/slurring in ≥2 congruent leads V1, V2,
V5, V6, I or aVL
Table 2
Intra- and interobserver agreement in LBBB classification.
Criterion Prevalence Intra-observer agreement (P) Kappa (K) Inter-observer agreement (P) Kappa (K)
ESC 0.75 ± 0.29 0.94 ± 0.05 0.67 ± 0.22 0.85 ± 0.08 0.27 ± 0.25
AHA/ACC/HRS 0.20 ± 0.27 0.87 ± 0.08 0.47 ± 0.28 0.81 ± 0.09 0.19 ± 0.25
MADIT 0.71 ± 0.31 0.95 ± 0.04 0.74 ± 0.19 0.88 ± 0.07 0.44 ± 0.22
Strauss 0.65 ± 0.32 0.92 ± 0.06 0.65 ± 0.22 0.85 ± 0.08 0.40 ± 0.22
Clinical judgement 0.50 ± 0.35 0.93 ± 0.05 0.76 ± 0.14 0.81 ± 0.08 0.35 ± 0.20
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above 150ms than in patients with a QRS duration b150ms, 0.68 (0.36)
versus 0.26 (0.34) respectively.
3.4. Inter-definition agreement in LBBB classification
Highest inter-definition agreement was observed between ESC and
MADIT definitions (P = 0.95 (0.07)), whereas lowest agreement was
seen between theAHA/ACC/HRS and theESC,MADIT andStrauss criteria
(P = 0.40, (0.22), P = 0.44, (0.23), and P = 0.50 (0.23) respectively).
3.5. Correspondence of clinical judgement with available definitions
As shown in Fig. 2, the clinical judgement of the presence of LBBB
correlated only modestly (phi coefficient range 0.10–0.68) to LBBB
according to the available definitions of LBBB. Clinical judgement corre-
lated best with Strauss definition (mean phi = 0.52 (0.10)) and worst
with AHA/ACC/HRS definition (mean phi = 0.30 (0.10)).
4. Discussion
The present study shows that LBBB classification by clinical judge-
ment as well as classification by use of definitions of LBBB shows signif-
icant interobserver, and to lesser extent intra-observer variability.
Variability seems to depend on the complexity of the definition of
LBBB. The probability of classifying an ECG as LBBB by clinical judge-
ment and available definitions varied considerably. Furthermore the
correlation between clinical judgement and the LBBB definitions was
poor. These results are important in the light of LBBB being an important
selection criterion for CRT. The lack of a standardized and well defined
classification of LBBB may hamper consistent selection of patients.
Moreover study results that have established the role of LBBB in patient
selection for CRT, may not be reproducible in daily practice.
4.1. Classification according to clinical judgement of LBBB
Clinical judgement of LBBB seems reproducible as it showed good
intra-observer agreement. Although still close to 1 in 10 ECGs will be
classified differently by the same observer. However, inter-observer
agreement is only 0.81, which implies that implanting cardiologists
will disagree on 1 in 5 ECGs. This large inter-observer variability exists
despite the fact that the observers in this study are experienced and
have been dealing with this issue extensively in research and clinical
settings. Although QRS duration influences the likelihood for a patient
to be classified as LBBB, no evidence of an influence of QRS duration
on the intra- and interobserver agreement was found. Meaning that
the subjectivity in LBBB classification depends predominantly on mor-
phological features. The 50 ± 0.35% prevalence of LBBB by clinical clas-
sification adds to the low kappa-value (0.35± 0.20)which translates to
the poor correlation with LBBB definitions.
The poor correlation of clinical judgement with LBBB classification
according to the definitions implies that the abundance of research
showing the relation of LBBB to improved outcomes in CRT may not
be applicable to LBBB based on clinical judgement.
Fig. 1. Prevalence of LBBB according to available definitions and clinical judgement. Summary of the estimated prevalence of LBBB according to four definitions each used by 4 observers
and clinical judgement made by 4 clinicians. Data are presented as mean (cross), median (bar), 25–75 percentiles (box) and minimum and maximum (dotted line). AHA= American
Heart Association, American College of Cardiology and Heart Rhythm Society conjoint definition of LBBB [18], CLI = clinical judgement, ESC = European Society of Cardiology [1],
MADIT = Multicenter Automatic Defibrillator Implantation Trial with Cardiac Resynchronization Therapy (MADIT-CRT) [6], Strauss = LBBB definition according to Strauss et al. [8].
Fig. 2. Correlation of clinical LBBB classification with classification according to available
LBBB definitions. Summary of the correlation (phi coefficient) between LBBB according
to clinical judgement and the four LBBB definitions. Data are presented as mean (cross),
median (bar), 25–75 percentiles (box) and minimum and maximum (dotted line).
Symbols and abbreviations are explained in the legends to Fig. 1.
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Since all observers were from Europe, a larger correlation of the clin-
ical judgementwith the ESC definitionwas expected thatwith the other
definitions. However, the correlation was the highest with the MADIT
and the Strauss LBBB definitions, the two least complex definitions.
These definitions also incorporate a larger QRS duration criterion,
which could reflect that clinical judgement is sensitive to wider QRS
duration, as was shown in this study.
4.2. Classification using different LBBB definitions
There is great variability in classification of LBBB according to differ-
ent definitions with AHA/ACC/HRS definitions classifying every other
ECG different from ESC, MADIT and Strauss definitions. This obviously
leads to great differences in implantation practice. However even
using Strauss and ESC or MADIT definitions will lead to a different clas-
sification in 1 out of 5 ECGs.
The probability of observing LBBB according to the definitions in-
vestigated in this study correlates well to findings in earlier studies
[4,6,10]. The REVERSE-trial subanalyses reported 60% patients to
show LBBB, whereas 70% of MADIT-CRT patients had LBBB on their
baseline 12-lead ECG. The REVERSE definition differs from the MADIT
definition by the inclusion of a shorter QRS duration, which would
make it less specific. The difference can also be explained by the differ-
ence in populations, with a largermeanQRS duration in theMADIT-trial
(158 ms) as compared to the REVERSE-trial (151 ms). Studies incorpo-
rating the Strauss LBBB definition report approximately 40% of patients
classified as LBBB [11]. Interestingly, a recent study investigated the
effect of the application of Strauss (strict) LBBB definition on CRT
patients that were included for ‘less’ strict criteria, according to the
AHA/ACC/HRS definition in the CRT MORE registry. In this subanalysis
only 39% of patients classified as LBBB by AHA/ACC/HRS definition,
were classified as LBBB by Strauss definition [12]. According to the cur-
rent analyses however AHA/ACC/HRS LBBB definition is far more spe-
cific than the definition Strauss and colleagues used. This once more
shows the complex nature of themorphological features the definitions
are composed of. The standard deviations shown in Fig. 2 confirm these
issues, even within our own group.
Intra-observer variability in LBBB classification using different LBBB
definitions is generally good, leading to less than 1 in 10 ECGs classified
differently by the same observer. Inter-observer variability however is a
little higher, with 1 in every 5 to 6 ECGs being classified differently by
different observers. The lower kappa values in comparison to the prob-
abilities reflect the respective prevalences of LBBB by different defini-
tions. Therefore the percentage of patients (0.20 ± 0.27) classified as
LBBB by AHA/ACC/HRS definition leads to relatively large difference in
probability (0.87± 0.08) and kappa (0.47± 0.28) values. The small dif-
ference in absolute probability between LBBB definitions therefore in-
creases with taking into account the prevalence of LBBB by the
different definitions. Moreover variability seems to depend on the com-
plexity of the definition. As the AHA/ACC/HRS definition entails judge-
ment of the presence of 8 separate morphological features, this is by
far the most complex definition. Easily misinterpreted morphological
criteria as ‘notching or slurring’ seem to contribute to the higher intra-
and interobserver variability. This becomes even more clear when
reviewing previous studies' summary of 12-lead ECG characteristics of
LBBB. Gold et al. [4] in the REVERSE-trial subanalyses, Zareba et al. [6]
in the MADIT-CRT-trial subanalyses, and Birnie et al. [3] in the RAFT-
trial subanalyses, all refer to the WHO classification [7] also used by
the AHA/ACC/HRS guidelines. The summary of these characteristics in
the respective papers however differ significantly from the original
WHO criteria that are referred to. Furthermore in the determination of
the presence of LBBB (according to the aforementioned definitions)
these trials all had a (trained) core-laboratory at their disposal. The re-
sults in the current analyses clearly show that this is not a good repre-
sentation of clinical practice as this reduces inter-observer variability
apart from inter-definition and intra-observer variability present in
every day clinical practice. Furthermore interpretation ofmorphological
criteria might also depend on the format and filtering of the ECG.When
a digital ECG is used, zooming in on the QRS-complex may reveal (or
seem to reveal) distinct criteria. When using a printed ECG however,
this is not possible. This has also been shown for the interpretation of
QRS duration [13].
A possible solution to the observed variability in using LBBB defini-
tions could be the use of automated detection algorithms. Xia et al.
[14] have shown this to be a feasible effort, with good correlation to
manual observation of LBBB by the Strauss definition (using 4 different
observers).
4.3. Limitations
This study did not include outcomes to CRT. Therefore this analysis
cannot show the implications for patient benefit from CRT. Although
this would further establish the importance of reaching consensus
on the definition of LBBB, this was not the primary aim of the current
analyses. A recent analysis by Caputo et al. [15] however showed that
the definition of LBBB indeed influences the association to CRT.Moreover
they show profound differences in patient populations (size) deemed
LBBB and non-LBBB by various LBBB definitions. This study stresses the
need for standardization of the definition of LBBB, or replacement by
alternative marker, which are not so sensitive to interpretation as LBBB.
A limitation in the selection of ECGs in this study, was that all ECGs
were from patients actually implanted with a CRT device. This may
have caused selection bias in the probability of scoring LBBB. It is
unlikely that this affected the variability in the classification of LBBB.
However, as observers using clinical judgement were different from
observers using LBBB definitions for classification, inter-observer vari-
ability could have influenced the relationship between clinical judge-
ment and LBBB definitions.
4.4. Clinical relevance
The observed variability in LBBB classificationmight in part be an ex-
planation for the high variations in patient selection for CRT and abiding
existence of non-response in every day practice [16,17]. The present
results also indicate that combining studies on outcome of CRT using
different LBBB definitions may produce unreliable indications about
the value of LBBB as selection criterion [1]. Finally, while results
from subanalyses of the MADIT and REVERSE trials have led to the in-
troduction of LBBB as a selection criterion in all CRT guidelines, this
study shows considerable difficulties in the application in daily clinical
practice.
5. Conclusions
Classification of the presence of LBBB on the ECG is not straightfor-
ward at all. There is considerable difference in identification of LBBB
by experienced cardiologists' clinical judgement, aswell as by observers
using the available LBBB definitions. Furthermore, clinical judgement of
LBBB correlates poorly with all of these LBBB definitions. These data in-
dicate that great variability in LBBB classification is bound to be present
between the landmark trails confirming the association between LBBB
and positive response to CRT, as well as in current CRT practice.
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